A detailed history of E. Ohman J:Or Asset Management Ab transactions in Boston Scientific Corp stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 660,385 shares of BSX stock, worth $59.7 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
660,385
Previous 694,844 4.96%
Holding current value
$59.7 Million
Previous $53.5 Billion 3.42%
% of portfolio
1.37%
Previous 1.33%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$72.96 - $84.0 $2.51 Million - $2.89 Million
-34,459 Reduced 4.96%
660,385 $55.3 Billion
Q2 2024

Aug 13, 2024

SELL
$67.33 - $77.71 $499,992 - $577,074
-7,426 Reduced 1.06%
694,844 $53.5 Billion
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $1.56 Million - $1.86 Million
27,055 Added 4.01%
702,270 $48.1 Billion
Q4 2023

Feb 15, 2024

SELL
$48.64 - $57.81 $2.31 Million - $2.75 Million
-47,533 Reduced 6.58%
675,215 $39 Billion
Q3 2023

Feb 06, 2024

BUY
$50.19 - $54.68 $36.3 Million - $39.5 Million
722,748 New
722,748 $38.2 Billion
Q2 2023

Apr 05, 2024

SELL
$49.72 - $54.64 $3.75 Million - $4.13 Million
-75,500 Reduced 36.78%
129,748 $7.02 Billion
Q1 2023

Apr 05, 2024

SELL
$45.09 - $50.03 $180,360 - $200,120
-4,000 Reduced 1.91%
205,248 $10.3 Billion
Q4 2022

Apr 05, 2024

SELL
$39.56 - $47.22 $110,768 - $132,216
-2,800 Reduced 1.32%
209,248 $9.68 Billion
Q3 2022

Apr 05, 2024

SELL
$36.71 - $109.66 $2.18 Million - $6.51 Million
-59,352 Reduced 21.87%
212,048 $8.21 Billion
Q2 2022

Apr 05, 2024

BUY
$35.24 - $47.1 $1.64 Million - $2.19 Million
46,400 Added 20.62%
271,400 $10.1 Billion
Q1 2022

Apr 05, 2024

BUY
$40.9 - $45.1 $9.2 Million - $10.1 Million
225,000 New
225,000 $9.97 Billion
Q4 2021

Apr 05, 2024

SELL
$38.07 - $44.87 $2.32 Million - $2.74 Million
-61,000 Closed
0 $0
Q2 2021

Apr 05, 2024

BUY
$38.58 - $44.24 $2.35 Million - $2.7 Million
61,000 New
61,000 $2.61 Billion
Q1 2021

Apr 05, 2024

SELL
$35.27 - $39.67 $920,547 - $1.04 Million
-26,100 Closed
0 $0
Q4 2020

Apr 05, 2024

SELL
$33.15 - $41.97 $195,585 - $247,623
-5,900 Reduced 18.44%
26,100 $938 Million
Q2 2020

Apr 05, 2024

BUY
$30.19 - $39.11 $966,080 - $1.25 Million
32,000 New
32,000 $1.12 Billion
Q2 2019

Apr 05, 2024

SELL
$34.91 - $42.98 $1.9 Million - $2.33 Million
-54,300 Closed
0 $0
Q1 2019

Apr 05, 2024

SELL
$32.91 - $40.75 $32,910 - $40,750
-1,000 Reduced 1.81%
54,300 $2.08 Billion
Q4 2018

Apr 05, 2024

SELL
$31.73 - $39.04 $314,127 - $386,496
-9,900 Reduced 15.18%
55,300 $1.95 Billion
Q3 2018

Apr 05, 2024

BUY
$32.83 - $38.63 $219,961 - $258,821
6,700 Added 11.45%
65,200 $2.51 Billion
Q2 2018

Apr 05, 2024

BUY
$26.84 - $34.32 $469,700 - $600,600
17,500 Added 42.68%
58,500 $1.91 Billion
Q1 2018

Apr 05, 2024

BUY
$25.2 - $28.54 $60,480 - $68,496
2,400 Added 6.22%
41,000 $1.12 Billion
Q4 2017

Apr 05, 2024

BUY
$24.79 - $29.8 $2,479 - $2,980
100 Added 0.26%
38,600 $957 Million
Q3 2017

Apr 05, 2024

BUY
$26.26 - $29.17 $31,512 - $35,004
1,200 Added 3.22%
38,500 $1.12 Billion
Q1 2017

Apr 05, 2024

BUY
N/A
7,000 Added 23.1%
37,300 $928 Million
Q3 2016

Apr 05, 2024

BUY
N/A
4,600 Added 17.9%
30,300 $721 Million
Q2 2015

Apr 05, 2024

SELL
N/A
-7,000 Reduced 21.41%
25,700 $455 Million
Q2 2013

Apr 05, 2024

SELL
N/A
-9,000 Reduced 21.58%
32,700 $303 Million
Q4 2012

Apr 05, 2024

BUY
N/A
15,000 Added 56.18%
41,700 $239 Million
Q2 2012

Apr 05, 2024

SELL
N/A
-25,500 Reduced 48.85%
26,700 $151 Million
Q1 2012

Apr 05, 2024

BUY
N/A
22,000 Added 72.85%
52,200 $312 Million
Q1 2011

Apr 05, 2024

BUY
N/A
7,900 Added 35.43%
30,200 $223 Million
Q2 2009

Apr 05, 2024

BUY
N/A
7,100 Added 46.71%
22,300 $226 Million
Q4 2007

Apr 05, 2024

BUY
N/A
4,700 Added 44.76%
15,200 $177 Million
Q4 2006

Apr 05, 2024

SELL
N/A
-664,715
10,500 $180 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track E. Ohman J:Or Asset Management Ab Portfolio

Follow E. Ohman J:Or Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E. Ohman J:Or Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on E. Ohman J:Or Asset Management Ab with notifications on news.